Characteristics of the patients with systemic lupus erythematosus analysed, clinical manifestations of the disease and other signs of disease activity underlying the ECLAM score
| Patient | Age (y) | Sex | PRL1-150(ng/ml) | ECLAM score | ANA1-150 1-151 | ENA1-150 | aCL IgG1-150 | aDNA IgG1-150 | CL-IF1-150 1-151 | Raised ESR1-150 | Decrease of C3/C4 | Fever/ fatigue | Skin | Joint | Haematological | Kidney | CNS1-150 |
| 1 | 21 | M | 6.4 | 3 | 2560 | Ro/La/Sm | ++ | 129.7 | 16 | − | − | + | + | − | − | + | − |
| 2 | 40 | M | 10.1 | 7 | 160 | Ro/La/Sm | ++ | 80 | 32 | + | + | + | + | + | + | + | − |
| 3 | 57 | F | 10.8 | 4 | 1280 | Ro/La | + | 11.6 | − | − | − | + | + | − | + | − | + |
| 4 | 30 | F | 34.3 | 10 | 640 | La | ++ | 225 | 128 | + | + | + | + | + | + | + | + |
| 5 | 21 | M | 20.5 | 4 | 1280 | Ro/La/Sm | ++ | 34.2 | 32 | − | + | − | − | − | + | + | − |
| 6 | 39 | F | 21.2 | 5 | 320 | Ro/La | − | − | − | + | − | + | + | − | + | + | − |
| 7 | 21 | F | 24.7 | 4 | 1280 | Ro/La | + | − | − | + | + | − | + | − | − | + | − |
| 8 | 48 | F | 19.8 | 10 | 10240 | Ro | ++ | 140 | 128 | + | + | + | + | + | + | − | − |
| 9 | 17 | F | 39.5 | 3 | 640 | − | − | 16 | 2 | + | + | − | − | − | − | + | − |
| 10 | 30 | F | 9.5 | 1 | 320 | − | + | 21.1 | − | + | − | − | − | − | − | − | − |
| 11 | 25 | F | 15.4 | 6 | 1280 | Ro/La | + | 26.3 | − | − | + | − | + | + | − | + | − |
↵1-150 PRL = prolactin; ANA = antinuclear antibodies; ENA = extactable nuclear antigens; aCL = anticardiolipin antibodies, positive (+) >50 U/ml, ++ >100 U/ml; aDNA = anti-dsDNA ELISA, positive ⩾6 AU; CL-IF = anti-dsDNA antibodies determined byCrithidia luciliae immunofluorescence technique; ESR = erythrocyte sedimentation rate; CNS = central nervous system.
↵1-151 Reciprocal titre, + means positive or present; − means negative or not present.